Skip to main content
Erschienen in: Medical Molecular Morphology 2/2014

01.06.2014 | Award Review

Recent classification of renal epithelial tumors

verfasst von: Naoto Kuroda, Azusa Tanaka

Erschienen in: Medical Molecular Morphology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

The recent classification of renal tumors is based on genetic evidence as well as on histologic features. Malignant tumor includes clear cell renal carcinoma (RCC), multilocular cystic RCC, papillary RCC, chromophobe RCC, carcinoma of the collecting duct of Bellini, renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and mucinous tubular and spindle cell carcinoma. Benign tumor is subdivided into papillary adenoma, renal oncocytoma and metanephric adenoma. Recently, new disease entities such as acquired cystic disease-associated RCC, clear cell papillary RCC and renal carcinoma with t(6;11)(p21:q12) have been discovered. In this article, we briefly review and introduce the clinical, morphological and genetic features of these tumor entities.
Literatur
1.
Zurück zum Zitat Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) (2004) World Health Organization Classification of Tumors. Pathology & Genetics. Tumours of the urinary system and male genital organ. IARC press, Lyon Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) (2004) World Health Organization Classification of Tumors. Pathology & Genetics. Tumours of the urinary system and male genital organ. IARC press, Lyon
2.
Zurück zum Zitat Amin MB, McKenney JK, Tickoo SK, Paner GP, Shen SS, Velazquez EF, Cubilla AL, Ro JY, Reuter VE (eds) (2010) Diagnostic pathology, genitourinary. Amirsys, LWW, Canada Amin MB, McKenney JK, Tickoo SK, Paner GP, Shen SS, Velazquez EF, Cubilla AL, Ro JY, Reuter VE (eds) (2010) Diagnostic pathology, genitourinary. Amirsys, LWW, Canada
3.
Zurück zum Zitat Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B, Lerman MI, Yao M (1994) Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 54:2852–2855PubMed Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B, Lerman MI, Yao M (1994) Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 54:2852–2855PubMed
4.
Zurück zum Zitat Nagashima Y, Inayama Y, Kato Y, Kanno H, Aoki I, Yao M (2004) Pathological and molecular biological aspects of the renal epithelial neoplasms, up-to-date. Pathol Int 54:377–386PubMedCrossRef Nagashima Y, Inayama Y, Kato Y, Kanno H, Aoki I, Yao M (2004) Pathological and molecular biological aspects of the renal epithelial neoplasms, up-to-date. Pathol Int 54:377–386PubMedCrossRef
5.
Zurück zum Zitat Sükösd F, Kuroda N, Beothe T, Kaur AP, Kovacs G (2003) Deletion of chromosome 3p14.2-p25 involving in the VHL and FHIT genes in conventional renal cell carcinoma. Cancer Res 63:455–457PubMed Sükösd F, Kuroda N, Beothe T, Kaur AP, Kovacs G (2003) Deletion of chromosome 3p14.2-p25 involving in the VHL and FHIT genes in conventional renal cell carcinoma. Cancer Res 63:455–457PubMed
6.
Zurück zum Zitat Williamson SR, Halat S, Eble JN, Grignon DJ, Lopez-Beltran A, Montironi R, Tan P-H, Wang M, Zhang S, MacLennan GT, Baldridge LA, Cheng L (2012) Multilocular cystic renal cell carcinoma. Similarities and difference in immunoprofile compared with clear cell renal cell carcinoma. Am J Surg Pathol 36:1425–1433PubMedCrossRef Williamson SR, Halat S, Eble JN, Grignon DJ, Lopez-Beltran A, Montironi R, Tan P-H, Wang M, Zhang S, MacLennan GT, Baldridge LA, Cheng L (2012) Multilocular cystic renal cell carcinoma. Similarities and difference in immunoprofile compared with clear cell renal cell carcinoma. Am J Surg Pathol 36:1425–1433PubMedCrossRef
7.
Zurück zum Zitat Kuroda N, Ohe C, Mikami S, Inoue K, Nagashima Y, Cohen RJ, Pan CC, Michal M, Hes O (2012) Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 27:969–974PubMed Kuroda N, Ohe C, Mikami S, Inoue K, Nagashima Y, Cohen RJ, Pan CC, Michal M, Hes O (2012) Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 27:969–974PubMed
8.
Zurück zum Zitat Delahunt B, Eble JN (1997) Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 10:537–544PubMed Delahunt B, Eble JN (1997) Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 10:537–544PubMed
9.
Zurück zum Zitat Kuroda N, Toi M, Hiroi M, Enzan H (2003) Review of papillary renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 18:487–494PubMed Kuroda N, Toi M, Hiroi M, Enzan H (2003) Review of papillary renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 18:487–494PubMed
10.
Zurück zum Zitat Thoenes W, Störkel S, Rumplet H-J, Moll R, Baum HP, Werner S (1988) Chromophobe cell renal carcinoma and its variant—a report of 32 cases. J Pathol 155:277–287PubMedCrossRef Thoenes W, Störkel S, Rumplet H-J, Moll R, Baum HP, Werner S (1988) Chromophobe cell renal carcinoma and its variant—a report of 32 cases. J Pathol 155:277–287PubMedCrossRef
11.
Zurück zum Zitat Nagashima Y (2000) Chromophobe renal cell carcinoma: clinical, pathological and molecular biological aspects. Pathol Int 50:872–878PubMedCrossRef Nagashima Y (2000) Chromophobe renal cell carcinoma: clinical, pathological and molecular biological aspects. Pathol Int 50:872–878PubMedCrossRef
12.
Zurück zum Zitat Kuroda N, Toi M, Hiroi M, Enzan H (2003) Review of chromophobe renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 18:165–171PubMed Kuroda N, Toi M, Hiroi M, Enzan H (2003) Review of chromophobe renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 18:165–171PubMed
13.
Zurück zum Zitat Fleming S, Lewi HJE (1986) Collecting duct carcinoma of the kidney. Histopathology 10:1131–1141PubMedCrossRef Fleming S, Lewi HJE (1986) Collecting duct carcinoma of the kidney. Histopathology 10:1131–1141PubMedCrossRef
14.
Zurück zum Zitat Kobayashi N, Matsuzaki O, Shirai S, Aoki I, Yao M, Nagashima Y (2008) Collecting duct carcinoma of the kidney: an immunohistochemical evaluation of the use of antibodies for differential diagnosis. Hum Pathol 39:1350–1359PubMedCrossRef Kobayashi N, Matsuzaki O, Shirai S, Aoki I, Yao M, Nagashima Y (2008) Collecting duct carcinoma of the kidney: an immunohistochemical evaluation of the use of antibodies for differential diagnosis. Hum Pathol 39:1350–1359PubMedCrossRef
15.
Zurück zum Zitat Kuroda N, Toi M, Hiroi M, Enzan H (2002) Review of collecting duct carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 17:1329–1334PubMed Kuroda N, Toi M, Hiroi M, Enzan H (2002) Review of collecting duct carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 17:1329–1334PubMed
16.
Zurück zum Zitat Armah HB, Parwani AV (2010) Xp11.2 translocation renal cell carcinoma. Arch Pathol Lab Med 134:124–129PubMed Armah HB, Parwani AV (2010) Xp11.2 translocation renal cell carcinoma. Arch Pathol Lab Med 134:124–129PubMed
17.
Zurück zum Zitat Kuroda N, Mikami S, Pan CC, Cohen RJ, Hes O, Michal M, Nagashima Y, Tanaka Y, Inoue K, Shuin T, Lee GH (2012) Review of renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with focus on pathobiological aspect. Histol Histopathol 27:133–140PubMed Kuroda N, Mikami S, Pan CC, Cohen RJ, Hes O, Michal M, Nagashima Y, Tanaka Y, Inoue K, Shuin T, Lee GH (2012) Review of renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with focus on pathobiological aspect. Histol Histopathol 27:133–140PubMed
18.
Zurück zum Zitat Rakozy C, Schmahl GE, Bogner S, Störkel S (2002) Low-grade tubular-mucinous renal neoplasms: morphologic, immunohistochemical, and genetic features. Mod Pathol 15:1162–1171PubMedCrossRef Rakozy C, Schmahl GE, Bogner S, Störkel S (2002) Low-grade tubular-mucinous renal neoplasms: morphologic, immunohistochemical, and genetic features. Mod Pathol 15:1162–1171PubMedCrossRef
19.
Zurück zum Zitat Kuroda N, Toi M, Hiroi M, Suin T, Enzan H (2005) Review of mucinous tubular and spindle-cell carcinoma of the kidney with focus on clinical and pathobiological aspects. Histol Histopathol 20:221–224PubMed Kuroda N, Toi M, Hiroi M, Suin T, Enzan H (2005) Review of mucinous tubular and spindle-cell carcinoma of the kidney with focus on clinical and pathobiological aspects. Histol Histopathol 20:221–224PubMed
20.
Zurück zum Zitat Amin MB, Crotty TB, Tickoo SK, Farrow GM (1997) Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. Am J Surg Pathol 21:1–12PubMedCrossRef Amin MB, Crotty TB, Tickoo SK, Farrow GM (1997) Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. Am J Surg Pathol 21:1–12PubMedCrossRef
21.
Zurück zum Zitat Perez-Ordonez B, Hamed G, Campbell S, Erlandson RA, Russo P, Gaudin S, Reuter VE (1997) Renal oncocytoma: a clinicopathologic study of 70 cases. Am J Surg Pathol 21:871–883PubMedCrossRef Perez-Ordonez B, Hamed G, Campbell S, Erlandson RA, Russo P, Gaudin S, Reuter VE (1997) Renal oncocytoma: a clinicopathologic study of 70 cases. Am J Surg Pathol 21:871–883PubMedCrossRef
22.
Zurück zum Zitat Kuroda N, Toi M, Hiroi M, Shuin T, Enzan H (2003) Review of renal oncocytoma with focus on clinical and pathobiological aspects. Histol Histopathol 18:935–942PubMed Kuroda N, Toi M, Hiroi M, Shuin T, Enzan H (2003) Review of renal oncocytoma with focus on clinical and pathobiological aspects. Histol Histopathol 18:935–942PubMed
23.
Zurück zum Zitat Grignon DV, Eble JN (1998) Papillary and metanephric adenomas of the kidney. Semin Diagn Pathol 15:41–53PubMed Grignon DV, Eble JN (1998) Papillary and metanephric adenomas of the kidney. Semin Diagn Pathol 15:41–53PubMed
24.
Zurück zum Zitat Wade Strong J, Ro JY (1996) Metanephric adenoma of the kidney: a newly characterized entity. Adv Anat Pathol 3:172–178CrossRef Wade Strong J, Ro JY (1996) Metanephric adenoma of the kidney: a newly characterized entity. Adv Anat Pathol 3:172–178CrossRef
25.
Zurück zum Zitat Kuroda N, Toi M, Hiroi M, Enzan H (2003) Review of metanephric adenoma of the kidney with focus on clinical and pathobiological aspects. Histol Histopathol 18:253–257PubMed Kuroda N, Toi M, Hiroi M, Enzan H (2003) Review of metanephric adenoma of the kidney with focus on clinical and pathobiological aspects. Histol Histopathol 18:253–257PubMed
26.
Zurück zum Zitat Sule N, Yakupoglu U, Shen SS, Krishnan B, Yang G, Lerner S, Sheikh-Hamad D, Troung LD (2005) Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study. Am J Surg Pathol 29:443–451PubMedCrossRef Sule N, Yakupoglu U, Shen SS, Krishnan B, Yang G, Lerner S, Sheikh-Hamad D, Troung LD (2005) Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study. Am J Surg Pathol 29:443–451PubMedCrossRef
27.
Zurück zum Zitat Tickoo SK, dePeralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN, Moch H, Amin MB (2006) Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30:141–153PubMedCrossRef Tickoo SK, dePeralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN, Moch H, Amin MB (2006) Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30:141–153PubMedCrossRef
28.
Zurück zum Zitat Kuroda N, Ohe C, Mikami S, Hes O, Michal M, Brunelli M, Martignoni G, Sato Y, Yoshino T, Kakehi Y, Shuin T, Lee GH (2011) Review of acquired cystic disease-associated renal cell carcinoma with focus on pathobiological aspects. Histol Histopathol 26:1215–1218PubMed Kuroda N, Ohe C, Mikami S, Hes O, Michal M, Brunelli M, Martignoni G, Sato Y, Yoshino T, Kakehi Y, Shuin T, Lee GH (2011) Review of acquired cystic disease-associated renal cell carcinoma with focus on pathobiological aspects. Histol Histopathol 26:1215–1218PubMed
29.
Zurück zum Zitat Kuroda N, Tamura M, Taguchi T, Tominaga A, Hes O, Michal M, Ohara M, Hirouchi T, Mizuno K, Hayashi Y, Shuin T, Lee GH (2008) Sarcomatoid acquired cystic disease-associated renal cell carcinoma. Histol Histopathol 23:1327–1331PubMed Kuroda N, Tamura M, Taguchi T, Tominaga A, Hes O, Michal M, Ohara M, Hirouchi T, Mizuno K, Hayashi Y, Shuin T, Lee GH (2008) Sarcomatoid acquired cystic disease-associated renal cell carcinoma. Histol Histopathol 23:1327–1331PubMed
30.
Zurück zum Zitat Kuroda N, Tamura M, Hamaguchi N, Mikami S, Pan CC, Brunelli M, Martignoni G, Hes O, Michal M, Lee GH (2011) Acquired cystic disease-associated renal cell carcinoma with sarcomatoid change and rhabdoid features. Ann Diagn Pathol 15:462–466PubMedCrossRef Kuroda N, Tamura M, Hamaguchi N, Mikami S, Pan CC, Brunelli M, Martignoni G, Hes O, Michal M, Lee GH (2011) Acquired cystic disease-associated renal cell carcinoma with sarcomatoid change and rhabdoid features. Ann Diagn Pathol 15:462–466PubMedCrossRef
31.
Zurück zum Zitat Ross H, Martignoni G, Argani P (2011) Renal cell carcinoma with clear cell and papillary features. Arch Pathol Lab Med 136:391–399CrossRef Ross H, Martignoni G, Argani P (2011) Renal cell carcinoma with clear cell and papillary features. Arch Pathol Lab Med 136:391–399CrossRef
32.
Zurück zum Zitat Kuroda N, Shiotsu T, Kawada C, Shuin T, Hes O, Michal M, Ohe C, Mikami S, Pan CC (2011) Clear cell papillary renal cell carcinoma and clear cell renal cell carcinoma arising in acquired cystic disease of the kidney: an immunohistochemical and genetic study. Ann Diagn Pathol 15:282–285PubMedCrossRef Kuroda N, Shiotsu T, Kawada C, Shuin T, Hes O, Michal M, Ohe C, Mikami S, Pan CC (2011) Clear cell papillary renal cell carcinoma and clear cell renal cell carcinoma arising in acquired cystic disease of the kidney: an immunohistochemical and genetic study. Ann Diagn Pathol 15:282–285PubMedCrossRef
33.
Zurück zum Zitat Argani P, Hawkins A, Griffin CA, Goldstein JD, Haas M, Beckwith JB, Mankinen CB, Perlman EJ (2001) A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21;q12) chromosome translocation. Am J Pathol 158:2089–2096PubMedCentralPubMedCrossRef Argani P, Hawkins A, Griffin CA, Goldstein JD, Haas M, Beckwith JB, Mankinen CB, Perlman EJ (2001) A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21;q12) chromosome translocation. Am J Pathol 158:2089–2096PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Argani P, Laé M, Hutchinson B, Reuter VE, Collins MH, Perentesis J, Tomaszewski JE, Brooks JS, Acs G, Bridge JA, Vargas SO, Davis IJ, Fisher DE, Ladanyi M (2005) Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol 29:230–240PubMedCrossRef Argani P, Laé M, Hutchinson B, Reuter VE, Collins MH, Perentesis J, Tomaszewski JE, Brooks JS, Acs G, Bridge JA, Vargas SO, Davis IJ, Fisher DE, Ladanyi M (2005) Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol 29:230–240PubMedCrossRef
35.
Zurück zum Zitat Petersson F, Vaněček T, Michal M, Martignoni G, Brunelli M, Halbhuber Z, Spagnolo D, Kuroda N, Yang XJ, Alvarado-Cabrero I, Hora M, Branžovský J, Trivunic S, Kacerovská D, Steiner P, Hes O (2012) A distinctive translocation of the kidney; “rosette forming”, t(6;11), HMB45-positive renal tumor: a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases. Hum Pathol 43:726–736PubMedCrossRef Petersson F, Vaněček T, Michal M, Martignoni G, Brunelli M, Halbhuber Z, Spagnolo D, Kuroda N, Yang XJ, Alvarado-Cabrero I, Hora M, Branžovský J, Trivunic S, Kacerovská D, Steiner P, Hes O (2012) A distinctive translocation of the kidney; “rosette forming”, t(6;11), HMB45-positive renal tumor: a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases. Hum Pathol 43:726–736PubMedCrossRef
36.
Zurück zum Zitat Debelenko LV, Raimondi SC, Daw N, Shivakumar BR, Huang D, Nelson M, Bridge JA (2011) Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum. Mod Pathol 24:430–442PubMedCrossRef Debelenko LV, Raimondi SC, Daw N, Shivakumar BR, Huang D, Nelson M, Bridge JA (2011) Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum. Mod Pathol 24:430–442PubMedCrossRef
37.
Zurück zum Zitat Mariño-Enríquez A, Ou W-B, Weldon CB, Fletcher JA, Pérez-Atayde AR (2011) ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Genes Chromosom Cancer 5:146–153CrossRef Mariño-Enríquez A, Ou W-B, Weldon CB, Fletcher JA, Pérez-Atayde AR (2011) ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Genes Chromosom Cancer 5:146–153CrossRef
38.
Zurück zum Zitat Sugawara E, Togashi Y, Kuroda N, Sakata S, Hatano S, Asaka R, Yuasa T, Yonese J, Kitagawa M, Mano H, Ishikawa Y, Takeuchi K (2012) Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method. Cancer 118:4427–4436PubMedCrossRef Sugawara E, Togashi Y, Kuroda N, Sakata S, Hatano S, Asaka R, Yuasa T, Yonese J, Kitagawa M, Mano H, Ishikawa Y, Takeuchi K (2012) Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method. Cancer 118:4427–4436PubMedCrossRef
39.
Zurück zum Zitat Sukov WR, Hodge JC, Lohse CM, Akre MK, Leibovich BC, Thompson RH, Cheville JC (2012) ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients. Mod Pathol 25:1516–1525PubMedCrossRef Sukov WR, Hodge JC, Lohse CM, Akre MK, Leibovich BC, Thompson RH, Cheville JC (2012) ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients. Mod Pathol 25:1516–1525PubMedCrossRef
Metadaten
Titel
Recent classification of renal epithelial tumors
verfasst von
Naoto Kuroda
Azusa Tanaka
Publikationsdatum
01.06.2014
Verlag
Springer Japan
Erschienen in
Medical Molecular Morphology / Ausgabe 2/2014
Print ISSN: 1860-1480
Elektronische ISSN: 1860-1499
DOI
https://doi.org/10.1007/s00795-013-0033-0

Weitere Artikel der Ausgabe 2/2014

Medical Molecular Morphology 2/2014 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …